Michael Levangie is a Cardiology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 10 publications with 487 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
25 Main St
Hyannis, MA 026013129
Telephone
508-778-1829Provider last certified this registry record 6 Feb 2025.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.6%Beta blocker17.7%Metoprolol Succinate58%Carvedilol15%Metoprolol Tartrate13%Atenolol7%Nebivolol Hcl4%Carvedilol Er3%Propranolol Hcl2%Part D<11 patientsStatin16.8%Atorvastatin Calcium54%Rosuvastatin Calcium33%Pravastatin Sodium9%Simvastatin4%Part D≥206 patients+ 20 more classes in this area
Blood & clotting
12.4%Factor Xa inhibitor10.1%Eliquis69%Xarelto31%Part D≥132 patientsP2Y12 inhibitor2%Clopidogrel86%Brilinta14%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.2%Potassium supplement0.7%Potassium Chloride100%Part D≥20 patientsProton pump inhibitor0.3%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TARGETED PROTEOMIC PROFILING OF CARDIOGENIC SHOCK IN THE CARDIAC INTENSIVE CARE UNIT: AN ANALYSIS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
Journal of the American College of Cardiology
2022 - CIRCULATING BIOMARKER PATTERNS IN PATIENTS WITH VASODILATORY CARDIOGENIC SHOCK IN THE CARDIAC INTENSIVE CARE UNIT: ANALYSIS FROM THE CRITICAL CARE CARDIOLOGY TRIALS NETWORK (CCCTN) REGISTRY
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”